APAS Reports

Analyses of data from the Australian Passive Antimicrobial Resistance Surveillance (APAS) system support effective infection prevention and control and antimicrobial stewardship programs.

Print

thumbnail_-_apas_report_2022

Australian Passive Antimicrobial Resistance Surveillance (APAS) – third-generation cephalosporin resistance in Escherichia coli and Klebsiella pneumoniae: prevalence of extended-spectrum β-lactamase (ESBL) phenotype

2022
Publication, report or update

This report provides analyses of trends for resistance to third-generation cephalosporins, such as ceftriaxone, in E. coli and K. pneumoniae captured through APAS from 2006 to 2021.

Australian Passive Antimicrobial Resistance Surveillance report

Australian Passive Antimicrobial Resistance Surveillance (APAS) First report: multi-resistant organisms

2018
Publication, report or update

This report highlights concerning results for three types of significant resistances in Australia:

  • Methicillin resistance in Staphylococcus aureus (MRSA)
  • Fluoroquinolone non-susceptibility in Escherichia coli
  • Vancomycin non-susceptibility in Enterococcus faecium

Topics
Antimicrobial resistance, use and stewardship
Back to top